Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Dispatch of Postal Ballot Notice to the Shareholders
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sanofi Consumer Healthcare India has dispatched a Postal Ballot Notice to shareholders for four ordinary resolutions to be voted on via remote e-voting from March 24 to April 22, 2026, with results due by April 24, 2026. The first two resolutions seek approval for material related party transactions: up to Rs 1,200 million with Opella Healthcare India (for consignment agency, business support, and allied services) and up to Rs 3,414 million with Opella Healthcare International SAS (for exports, imports of finished goods and APIs), both for the financial year ending December 31, 2026. The third resolution seeks approval to continue paying Non-Executive Directors a commission capped at 1% of net profits for five years from January 2025 to December 2029. The fourth resolution seeks approval to amend the remuneration of Managing Director Mr. Himanshu Bakshi to enable his participation in a Global Long Term Incentive Plan worth €168,000 vesting over 21–36 months, along with revised fixed compensation of Rs 1.66 crore basic salary and Rs 1.38 crore special allowance.
These are routine governance items that are largely procedural and unlikely to move the stock. The related party transactions with group entities (Opella) are sizeable but stated to be at arm's length and in the ordinary course of business. The MD's LTI plan is designed to align his pay with long-term company performance, which is a positive governance signal for retail investors.